Thyrocare Technologies' Q4 FY 2025-26 Quarterly Results

Result Summary

• Thyrocare Technologies Ltd reported a 13.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 19.0%.
• Its expenses for the quarter were up by 3.2% QoQ and 14.2% YoY.
• The net profit increased 73.6% QoQ and increased 125.8% YoY.
• The earnings per share (EPS) of Thyrocare Technologies Ltd stood at 2.98 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Thyrocare Technologies Ltd is a prominent player in the healthcare industry, specializing in diagnostic and preventive healthcare services. The company is renowned for its extensive network of diagnostic centers and state-of-the-art laboratory facilities. Thyrocare offers a wide range of diagnostic tests, with a significant focus on preventive healthcare and wellness. The company has leveraged technology to provide efficient and reliable diagnostic solutions, making it a leader in the sector. Recent developments in the company have seen an expansion of services and a focus on enhancing digital healthcare delivery, although specific major developments in recent quarters are not available from the data provided.

Revenue

In Q4FY26, Thyrocare Technologies Ltd reported a total income of ₹228.26 crores, marking a strong performance compared to the previous quarters. This represents a quarter-over-quarter (QoQ) increase of 13.8% from ₹200.51 crores in Q3FY26. Year-over-year (YoY), the total income improved by 19.0% from ₹191.75 crores in Q4FY25. These figures indicate a robust growth trajectory for the company's revenue streams within the fiscal year. Despite the lack of detailed breakdowns of revenue sources, the significant growth in total income suggests an overall positive trend in revenue generation for the company during this quarter.

Profitability

Thyrocare Technologies Ltd demonstrated substantial improvements in profitability for Q4FY26. The profit before tax was recorded at ₹63.85 crores, showing an impressive QoQ growth of 81.9% from ₹35.11 crores in Q3FY26, and a YoY increase of 33.5% from ₹47.82 crores in Q4FY25. The tax expense for the quarter was ₹15.73 crores, which increased by 114.3% QoQ but decreased by 38.6% YoY. The profit after tax for the period stood at ₹48.70 crores, reflecting a QoQ growth of 73.6% from ₹28.05 crores and a significant YoY growth of 125.8% from ₹21.57 crores. Despite a decline in earnings per share (EPS) from ₹4.16 in Q4FY25 to ₹2.98 in Q4FY26, the overall profitability metrics indicate a positive financial performance for the quarter.

Operating Metrics

The total expenses for Q4FY26 were ₹164.41 crores, representing a modest QoQ increase of 3.2% from ₹159.24 crores in Q3FY26 and a YoY increase of 14.2% from ₹143.93 crores in Q4FY25. The controlled growth in expenses compared to the increase in total income highlights efficient operational management. The significant increase in profit before tax and profit after tax indicates effective cost management and operational efficiency. Earnings per share for Q4FY26 were ₹2.98, reflecting a QoQ increase of 64.6% from ₹1.81 in Q3FY26, although showing a YoY decline of 28.4% from Q4FY25. These metrics suggest an overall positive operational performance, with substantial profitability improvements despite the mixed trend in earnings per share.